AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

646.103

-8.938-1.36%

Number of Gainers:2

Number of Losers:21

Number of Flat:20

PE:- -

High:650.841

Open:649.570

Low:637.834

Close:655.041

Volume:52.58M

Turnover:141.81M

Market Cap:91.64B

Float Cap:88.40B

Loading ...

Actinogen Medical - Confirm That Company is in Compliance with Listing Rule 3.1

THOMSON REUTERS

CSL Says Vanguard Group Raises Stake

MT Newswires Live

Australia's Immuron Hits Near 1.5-Month High on Distribution Deal in US

Biotron Ltd-Change of Share Registry

THOMSON REUTERS

Dimerix Secures AU$34 Million in Non-Dilutive Loan Facility Agreements; Shares Up 4%

MT Newswires Live

Immuron - Executes Exclusive Distribution Agreement for Proibs in the United States

THOMSON REUTERS

Dimerix Ltd - Secures A$34 Mln Non-Dilutive Funding Facility

THOMSON REUTERS

Australian Shares Rise as Miners, Banks Gain on Lower Oil, Bond Yields

ASX Penny Stocks To Watch In September 2026

Simply Wall St.

Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module

Black Box Warning on CSL's Injectafer Unlikely to Change Much

Imricor Medical Systems, - FDA to Conduct Pre-Approval Inspection of Imricor's Manufacturing Sites

THOMSON REUTERS

Imricor Medical Systems, Inc-FDA Accepts Imricor Pma Manufacturing Module

THOMSON REUTERS

Prescient Therapeutics Hits Dose Optimization Review Milestone in Cancer Drug Study

MT Newswires Live

CSL Bulls Don't See Large Impact from U.S. Pricing Deals

Tissue Repair - Resumes Direct Distribution of Tr Pro+ in Australia and New Zealand

THOMSON REUTERS

Dimerix - Trading Halt Requested Pending Announcement on Non-Dilutive Funding Arrangements

THOMSON REUTERS

Here's Why We're Not Too Worried About AnteoTech's (ASX:ADO) Cash Burn Situation

Simply Wall St.

ASX Growth Companies With High Insider Ownership You Should Know

Simply Wall St.

3 ASX Stocks Estimated To Be Undervalued In September 2026

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BK7508/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":646.1032,"timestamp":1789019999458,"preClose":655.0414,"halted":0,"volume":52580641,"delay":0,"changeRate":-0.013645,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-8.938171,"latestTime":"09-10 16:00:00 AEST","open":649.5704,"high":650.84106,"low":637.8342,"amount":141806184,"amplitude":0.019857,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788998400000,1789020000000]],"turnoverRate":0.002063,"increases":3,"decrements":21,"flats":19,"marketCap":91635354181.75,"floatMarketCap":88396021898.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":650.84106,"amplitude":0.019857,"preClose":655.0414,"low":637.8342,"latestPrice":646.1032,"volume":52580641,"delay":0,"open":649.5704,"prevYearClose":644.3692,"prevWeekClose":666.366,"prevMonthClose":656.138,"prevQuarterClose":464.145,"fiveDayClose":670.585,"twentyDayClose":549.539,"sixtyDayClose":447.436,"secType":"PLATE","market":"AU","turnoverRate":0.002063,"marketCap":91635354181.75,"floatMarketCap":88396021898.625,"timestamp":1789019999458,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":2,"down":21,"flat":20},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664843381","title":"Actinogen Medical - Confirm That Company is in Compliance with Listing Rule 3.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843381?lang=en_us&edition=fundamental","pubTime":"2026-09-04 13:56","pubTimestamp":1788501366,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44V19F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACW.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664138693","title":"CSL Says Vanguard Group Raises Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138693","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138693?lang=en_us&edition=fundamental","pubTime":"2026-09-04 11:58","pubTimestamp":1788494293,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) said Vanguard Group raised its voting power in the firm to 7.001% as of Aug. 31 from 6% previously, according to a Friday Australian bourse filing.Vanguard holds 33.5 million ordinary shares in the firm as of Aug. 31, per the filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","BK7508","BK7067","BK7511","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664863123","title":"Australia's Immuron Hits Near 1.5-Month High on Distribution Deal in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863123","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664863123?lang=en_us&edition=fundamental","pubTime":"2026-09-04 11:41","pubTimestamp":1788493288,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Immuron hits near 1.5-month high on distribution deal in US** Shares ofAustralia'sImmuronIMC.AXsoar as much as 18.9% to A$0.044,theirhighest since July 20** Stock set forits biggest gainsince August 26** The biopharmaceutical company enters into an exclusive distribution agreement for digestive health productPROIBSin the U.S. withSwedish life science firmCalmino group AB** Nearly935,000shares change hands, around 8.1x 30-day average** YTD, stock up 11.1%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL4N44W077:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238884","title":"Biotron Ltd-Change of Share Registry","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664238884?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:08","pubTimestamp":1788484108,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nTUE1TQ5SS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","BIT.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664800459","title":"Dimerix Secures AU$34 Million in Non-Dilutive Loan Facility Agreements; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800459","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800459?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:40","pubTimestamp":1788482421,"startTime":"0","endTime":"0","summary":"Dimerix  secured non-dilutive loan facility agreements with a syndicate of Australian and US-based lenders to access up to AU$34 million, according to a Friday Australian bourse filing.This included a previously announced initial facility agreement of AU$10 million with Skiptan, per the filing. The firm confirmed that it was funded through to completion of the Action3 phase 3 trial in DMX-200, as well as the planned phase 2 clinical trial in DMX-652.The facility carries an interest rate of 10% per year, compounding annually, the company said. The receipt of the initial 50% draw-down is anticipated by Sept. 18, and the remainder is expected to take place at the firm's discretion on or before March 31, 2027.The facility provides the flexibility for Dimerix to elect to take further commitments for up to a total of AU$50 million on or before March 31, 2027.The biopharmaceutical company's shares were up 4% in recent Friday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DXB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664807855","title":"Immuron - Executes Exclusive Distribution Agreement for Proibs in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2664807855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664807855?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:25","pubTimestamp":1788477919,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","IMC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664802749","title":"Dimerix Ltd - Secures A$34 Mln Non-Dilutive Funding Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2664802749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664802749?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:17","pubTimestamp":1788477460,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","DXB.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664282421","title":"Australian Shares Rise as Miners, Banks Gain on Lower Oil, Bond Yields","url":"https://stock-news.laohu8.com/highlight/detail?id=2664282421","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664282421?lang=en_us&edition=fundamental","pubTime":"2026-09-03 15:13","pubTimestamp":1788419596,"startTime":"0","endTime":"0","summary":"Australian shares rise as miners, banks gain on lower oil, bond yieldsSept 3 (Reuters)-Australian shares rebounded from a one-month low on Thursday, led by heavyweight banks, as easing oil prices and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V0E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","LU1430597077.USD","LU0788109121.HKD","SG9999001143.SGD","BK5111","LU0971552830.HKD","LU0345781412.USD","BK7007","LU0612318971.USD","BK7067","IE00BWDBJ516.SGD","BK7511","LU0011963245.USD","LU0264606111.USD","LU0266512473.USD","LU0505663152.USD","LU0572940350.SGD","LU0612318385.USD","LU0654597011.USD","LU0955623706.USD","LU0955648018.USD","LU1078025761.USD","LU0345780950.USD","IE0034235071.USD","LU1064927863.SGD","BK7508","STO.AU","BK7095","LU0955669360.SGD","BK7501","BHP.AU","LU0330918003.SGD","LU0345777659.USD","IE00BQJZX424.USD","LU1130305938.SGD","LU0456854461.SGD","LU0572939691.SGD","LU1046248800.SGD","LU1481600234.SGD","LU0075056555.USD","RIO.UK","LU1302929846.USD","CSL.AU","IE00B3M56506.USD","BK7507","BK7142","LU0161305163.EUR","LU0971552673.USD","LU0831103253.SGD","LU0171293334.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664601823","title":"ASX Penny Stocks To Watch In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664601823","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664601823?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:04","pubTimestamp":1788401097,"startTime":"0","endTime":"0","summary":"The Australian stock market is poised for a positive start today, with the ASX expected to open higher following a rebound on Wall Street. Amidst this backdrop of fluctuating indices and evolving economic trends, investors are increasingly looking at opportunities in less conventional areas. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still present valuable opportunities when they possess strong financial foundations and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-penny-stocks-to-watch-in-september-2026-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-penny-stocks-to-watch-in-september-2026-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["KSC.AU","BK7508","BVS.AU","MSB.AU","BK7503","BK7067","BK7501","BK7016","BK7058"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664842977","title":"Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2664842977","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664842977?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:46","pubTimestamp":1788392770,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing ModuleSept 3 -Imricor Medical Systems, IncIMR.AX:IMRICOR MEDICAL SYSTEMS, INC-FDA ACCEPTS IMRICOR PMA MANUFACTURING MODULEIMRICOR MEDICAL SYSTEMS, - FDA ACCEPTS AND CLOSES IMRICOR'S PMA MANUFACTURING MODULEIMRICOR MEDICAL SYSTEMS, - FDA TO CONDUCT PRE-APPROVAL INSPECTION OF IMRICOR'S MANUFACTURING SITESFurther company coverage:IMR.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUEBD40TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7503","BK7007","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664426518","title":"Black Box Warning on CSL's Injectafer Unlikely to Change Much","url":"https://stock-news.laohu8.com/highlight/detail?id=2664426518","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664426518?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:34","pubTimestamp":1788392040,"startTime":"0","endTime":"0","summary":"2329 GMT [Dow Jones]--The addition of a black box warning to the label of CSL's Injectafer is unlikely to have a big impact, according to Citi. The Food and Drug Administration approved revised labeling for the iron replacement medicine to warn of the risk of low levels of phosphate in the blood. \"We do not think it will change much,\" says Citi. \"Generics to Injectafer have become available over the last few weeks and, per FDA, are expected to update their labels also.\" Citi has a neutral rating and A$160/share target on CSL. The stock ended Wednesday at A$173.85.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","BK7511","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844156","title":"Imricor Medical Systems, - FDA to Conduct Pre-Approval Inspection of Imricor's Manufacturing Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844156?lang=en_us&edition=fundamental","pubTime":"2026-09-03 06:21","pubTimestamp":1788387678,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUEBD40TZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","IMR.AU","BK7508","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664784413","title":"Imricor Medical Systems, Inc-FDA Accepts Imricor Pma Manufacturing Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2664784413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664784413?lang=en_us&edition=fundamental","pubTime":"2026-09-03 06:21","pubTimestamp":1788387678,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUEBD40TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7007","BK7508","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664999896","title":"Prescient Therapeutics Hits Dose Optimization Review Milestone in Cancer Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664999896","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664999896?lang=en_us&edition=fundamental","pubTime":"2026-09-02 13:38","pubTimestamp":1788327489,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics  reached the pre-specified enrollment threshold for its first planned dose optimization committee review in a phase 2a study of its PTX-100 drug candidate in relapsed or refractory cutaneous T-cell lymphoma, according to a Wednesday filing with the Australian bourse.The company said 10 evaluable patients, or those who have completed four cycles of treatment, are now enrolled in each of the study's two dosing arms for 20 evaluable patients in total.The first dose optimization committee review remains on track for December, and enrollment in the study continues globally toward a full target of 40 evaluable patients.Cutaneous T-cell lymphoma is a type of immune system cancer where abnormal white blood cells migrate to and attack the skin.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LENZ","PTX.AU","BK7508","BK4539","BK7067","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664918898","title":"CSL Bulls Don't See Large Impact from U.S. Pricing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664918898","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664918898?lang=en_us&edition=fundamental","pubTime":"2026-09-02 10:29","pubTimestamp":1788316140,"startTime":"0","endTime":"0","summary":"0229 GMT - CSL's bulls at UBS don't think the Australia-based pharmaceutical company will experience much of a direct financial impact from its U.S. pricing agreements. CSL has agreed to give Medicaid access to medicines at prices comparable to those in other developed economies, but the investment bank's analysts point out that the state-based program accounts for a relatively small part of its U.S. sales. On top of that, they don't see obligations around the pricing of future drug launches as onerous, given that CSL will be in control of settings and able to manage the impact in its best interests. UBS has a last-published buy rating on the stock and a target price of 181.00 Australian dollars. Shares are up 0.5% at A$173.12.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","BK7501","CSL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664862357","title":"Tissue Repair - Resumes Direct Distribution of Tr Pro+ in Australia and New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2664862357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664862357?lang=en_us&edition=fundamental","pubTime":"2026-09-02 07:58","pubTimestamp":1788307093,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T18J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRP.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664864668","title":"Dimerix - Trading Halt Requested Pending Announcement on Non-Dilutive Funding Arrangements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664864668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664864668?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:43","pubTimestamp":1788302639,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T15S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","DXB.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664675118","title":"Here's Why We're Not Too Worried About AnteoTech's (ASX:ADO) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2664675118","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664675118?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:26","pubTimestamp":1788297996,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ado/anteotech-shares/news/heres-why-were-not-too-worried-about-anteotechs-asxado-cash","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ado/anteotech-shares/news/heres-why-were-not-too-worried-about-anteotechs-asxado-cash","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","BK7036","ADO.AU","BK7048","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664320861","title":"ASX Growth Companies With High Insider Ownership You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2664320861","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664320861?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:08","pubTimestamp":1788289704,"startTime":"0","endTime":"0","summary":"Amidst a backdrop of geopolitical tensions in the Middle East and fluctuating oil prices, the Australian market is experiencing volatility, with the S&P/ASX 200 expected to open lower following Wall Street's decline. In such uncertain times, identifying growth companies with high insider ownership can offer insights into potential resilience and confidence within those businesses.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/asx-growth-companies-with-high-insider-ownership-you-should","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/asx-growth-companies-with-high-insider-ownership-you-should","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TLX","BK7096","EIQ.AU","VAP.AU","QRE.AU","OZR.AU","TLX.AU","OZF.AU","GEAR.AU","E200.AU","BBOZ.AU","SKS.AU","IMLC.AU","PDI.AU","QFN.AU","BK7501","IOZ.AU","IIGF.AU","BK7016","EIGA.AU","BK7110","SPL.AU","ZYAU.AU","XKO.AU","AV1.AU","FRS.AU","DACE.AU","GYG.AU","XAO.AU","BK7023","STW.AU","XJO.AU","BK7067","BK7137","IISV.AU","BK7093","BK7036","SLF.AU","GIVE.AU","VAS.AU","WZR.AU","BK4139","BK7504","LTR.AU","AWJ.AU","AR1.AU","BK7104","BEAR.AU","TTT.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861352","title":"3 ASX Stocks Estimated To Be Undervalued In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861352","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861352?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:05","pubTimestamp":1788289503,"startTime":"0","endTime":"0","summary":"As geopolitical tensions in the Middle East contribute to volatility in global markets, the Australian Stock Exchange (ASX) is feeling the impact with a cautious start, influenced by fluctuating oil prices and broader economic concerns. In such uncertain times, identifying undervalued stocks can offer potential opportunities for investors seeking resilience amidst market fluctuations.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice1-main-header/1585186655666","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice1-main-header/1585186655666"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/diversified-financials/asx-pni/pinnacle-investment-management-group-shares/news/3-asx-stocks-estimated-to-be-undervalued-in-september-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/diversified-financials/asx-pni/pinnacle-investment-management-group-shares/news/3-asx-stocks-estimated-to-be-undervalued-in-september-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SDV.AU","BK7015","BK4141","BK7016","BMT.AU","ASX","BK7508","MP1.AU","PNI.AU","BK7061","BK7043","CAT.AU","BK7126","BK7084","SLC.AU","BK7062","BK7503","BK7017","PNV.AU","NXL.AU","BK7120","TEA.AU","BK4543","BK7055","STH.AU","BK4526","ASX.AU","GNP.AU","BK4585","BK7039","LOV.AU","SPHQ","BK7094","BK4588","BK7128","NDO.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":137,"code":"91000000","status":"200"}]}}